I-test 2: novel retinal biomarkers in pregnancy for early prediction of stillbirth

Project Details

StatusActive
Effective start/end date1/09/2330/11/24

Funding

  • Wellcome Leap Inc: £22,544.78
  • Wellcome Leap Inc: £5,332.58
  • Wellcome Leap Inc: £585,938.84
  • Wellcome Leap Inc: £140,430.44